|
⚲
|
| Keyboard |
| Benitec Biopharma Inc | |
|---|---|
| Ticker | BNTC |
| CIK # | 0001808898 |
| CUSIP | 082053307 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | Level 14, 114 William St, Melbourne, Vic, 3000 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Benitec Biopharma Inc | 2024-04-25 | 40.0 M | Exemption: 506(b) · Duration: One year or less · Commission: $2,400,001 · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001808898] | 10-K | |
| [0001808898] | 10-Q | |
| [0001808898] | 3 | |
| [0001808898] | 4 | |
| [0001808898] | 8-K | |
| [0001808898] | D | |
| [0001808898] | SC 13D | |
| [0001808898] | SC 13G |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mates Sharon
Options (right to buy) · derivative
|
2026-01-22 | Grant | 31,500 | $0.00 | |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-29 | Buy | 11,587 | $13.44 | 155,729 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-29 | Buy | 65,800 | $13.44 | 884,352 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-26 | Buy | 14,320 | $13.10 | 187,592 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-26 | Buy | 2,516 | $13.10 | 32,960 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-23 | Buy | 42,600 | $12.85 | 547,410 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-23 | Buy | 7,400 | $12.85 | 95,090 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-22 | Buy | 16,650 | $12.08 | 201,132 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-22 | Buy | 2,892 | $12.08 | 34,935 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-19 | Buy | 2,434 | $11.48 | 27,942 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-19 | Buy | 13,950 | $11.48 | 160,146 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-18 | Buy | 8,700 | $11.24 | 97,788 |
|
Averill Master Fund Ltd +3
Common stock, par value $0.0001 per share
|
2025-12-18 | Buy | 1,515 | $11.24 | 17,029 |
|
Buchi J Kevin
Options (right to buy) · derivative
|
2025-12-01 | Grant | 35,000 | $0.00 | |
|
Mates Sharon
Options (right to buy) · derivative
|
2025-12-01 | Grant | 3,500 | $0.00 | |
|
Mehta Kishan
Options (right to buy) · derivative
|
2025-12-01 | Grant | 35,000 | $0.00 | |
|
Smith Edward F
Options (right to buy) · derivative
|
2025-12-01 | Grant | 35,000 | $0.00 | |
|
Francis Peter
Options (right to buy) · derivative
|
2025-12-01 | Grant | 35,000 | $0.00 | |
|
Mukadam Sophie
Options (right to buy) · derivative
|
2025-11-18 | Grant | 500,000 | $0.00 | |
|
Banks Jerel A
Options (right to buy) · derivative
|
2025-11-18 | Grant | 450,000 | $0.00 | |
| showing 20 of 88 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 88 | 32,483,199 |
| 2025-12-31 | 72 | 31,648,835 |
| 2025-09-30 | 56 | 23,161,306 |
| 2025-06-30 | 59 | 22,685,674 |
| 2025-03-31 | 38 | 21,867,281 |
| 2024-12-31 | 31 | 18,997,897 |
| 2024-09-30 | 26 | 13,715,023 |
| 2024-06-30 | 20 | 6,354,459 |
| 2024-03-31 | 14 | 1,294,437 |
| 2023-12-31 | 14 | 1,202,715 |
| 2023-09-30 | 13 | 1,267,970 |
| 2023-06-30 | 18 | 11,056,879 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Simplify Asset Management Inc | [2026-06-30] | SOLE | 1,005,557 | 1,005,557 |
| Gamma Investing LLC | [2026-06-30] | DFND | 7,961 | 7,961 |
| True Wealth Design LLC | [2026-06-30] | SOLE | 0 | 23 |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 20 | Prev | Page 1 | Next |